Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Facchini

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|February 1, 1992
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patientsP Fioretti, A Gadducci, M Ferdeghini, et al.
European Journal of Gynaecological Oncology|January 1, 1989
Surgery and radiotherapy in the treatment of early stage uterine sarcomasA Gadducci, M G Fabrini, V Facchini, et al.
Anticancer Research|September 1, 1995
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancerM Ferdeghini, A Gadducci, C Prontera, et al.
Gynecologic Oncology|August 12, 1998
Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Castellani, et al.
Anticancer Research|September 1, 1996
Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancerA Gadducci, M Ferdeghini, A Fanucchi, et al.
American Journal of Obstetrics and Gynecology|January 15, 1984
Lack of correlation between amniotic fluid and maternal plasma contents of beta-endorphin, beta-lipotropin, and adrenocorticotropic hormone in normal and pathologic pregnanciesA R Genazzani, F Petraglia, D Parrini, et al.
European Journal of Gynaecological Oncology|January 1, 1994
Immunohistochemical detection of p185 product, p21 product, and proliferating cell nuclear antigen (PCNA) in formalin-fixed, paraffin-embedded tissues from ovarian carcinomas. Preliminary dataA Gadducci, E M Ciancia, D Campani, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|January 1, 1985
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary]A Gadducci, M Ferdeghini, B Prato, et al.
Gynecologic Oncology|March 1, 1994
Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancerA Gadducci, M Ferdeghini, G Malagnino, et al.
European Journal of Gynaecological Oncology|January 1, 1985
Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancerV Facchini, A Gadducci, G Bogi, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|February 1, 1992
The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patientsP Fioretti, A Gadducci, M Ferdeghini, et al.
European Journal of Gynaecological Oncology|January 1, 1989
Surgery and radiotherapy in the treatment of early stage uterine sarcomasA Gadducci, M G Fabrini, V Facchini, et al.
Anticancer Research|September 1, 1995
Preoperative serum intercellular adhesion molecule-1 (ICAM-1) and E-selectin (endothelial cell leukocyte adhesion molecule, ELAM-1) in patients with epithelial ovarian cancerM Ferdeghini, A Gadducci, C Prontera, et al.
Gynecologic Oncology|August 12, 1998
Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancerA Gadducci, M Ferdeghini, C Castellani, et al.
Anticancer Research|September 1, 1996
Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancerA Gadducci, M Ferdeghini, A Fanucchi, et al.
American Journal of Obstetrics and Gynecology|January 15, 1984
Lack of correlation between amniotic fluid and maternal plasma contents of beta-endorphin, beta-lipotropin, and adrenocorticotropic hormone in normal and pathologic pregnanciesA R Genazzani, F Petraglia, D Parrini, et al.
European Journal of Gynaecological Oncology|January 1, 1994
Immunohistochemical detection of p185 product, p21 product, and proliferating cell nuclear antigen (PCNA) in formalin-fixed, paraffin-embedded tissues from ovarian carcinomas. Preliminary dataA Gadducci, E M Ciancia, D Campani, et al.
Annali Di Ostetricia, Ginecologia, Medicina Perinatale|January 1, 1985
[Tumor markers: new prospects in the diagnosis and clinical monitoring of malignant epithelial neoplasms of the ovary]A Gadducci, M Ferdeghini, B Prato, et al.
Gynecologic Oncology|March 1, 1994
Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancerA Gadducci, M Ferdeghini, G Malagnino, et al.
European Journal of Gynaecological Oncology|January 1, 1985
Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancerV Facchini, A Gadducci, G Bogi, et al.
Pageof 11